Stocks / NASDAQ / Organovo Holdings, Inc.

Organovo Holdings, Inc.

Industry: Health Care – Biotechnology: Biological Products (No Diagnostic Substances)

Stock Symbol: ONVO – NASDAQ

Animal Usage: Animal Testing

Our Opinion

Organovo Holdings, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“The company presented new preclinical data showing extended survival and sustained functionality of its 3D bioprinted human liver tissue when implanted into diseased animal models.” Read the following article

Company Description

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA. [Source: MarketWatch]

Company Website: http://organovo.com

Contact: http://www.organovo.com/about/contact; IR: skunszabo@organovo.com;